Remi Meds NAD+ prices
2 figures read September 2026.
Remi Meds publishes a standing rate of $349 for NAD+, but never on a calendar month — it bills on a cycle of its own, and the difference is the whole reason this page prints the seller's own wording for it.
What Remi Meds publishes
Remi Meds publishes a standing rate, but never on a calendar month — it bills every 4 weeks, every 28 days, or across a multi-month term. Of the 11 sellers in this index that fall in the same bucket, that puts it with the 10% of the roster that publishes this shape of number rather than another one. A standing rate charged on a calendar month is the only figure this site treats as a monthly price, and 60 of the 106 sellers in this index — including this one — do not publish one.
The figure above is a standing rate, “30-day supply of the medication, shipped every 30 days.”. This site never prints a price without that qualifier, on any surface, because the same number means a different thing depending on it — and in this corpus the same seller often prints several.
Every figure Remi Meds publishes — 2 figures, read September 2026
| Figure | What it is | Cycle, in their words | Route | Dose | Read |
|---|---|---|---|---|---|
| $349 | standing rate | “30-day supply of the medication, shipped every 30 days.” | Oral | 200 mg, 30 count troches | September 2026 |
| $349 | standing rate | “30-day supply of the medication, shipped every 30 days.” | SubQ | 10 ml per week | September 2026 |
In Remi Meds’s own words
- $349 standing rate
The page says: “NAD+ Troche - 200 mg Troches 30 Count | $349 ~ starting dose”
A troche is dissolved in the mouth, so this is oral/sublingual NAD+ itself, not an NMN/NR precursor — 'oral-precursor' is used only because the enum has no plain oral value. The page also states 'Dosage prescribed is determined by the licensed provider based on medical judgment' and marks $349 as the '~ starting dose' price.
Read from https://remimeds.com/services/nad-troches/ on September 2026.
- $349 standing rate
The page says: “NAD+ 10 ml per week | $349/mo ~ starting dose”
The page says 'injections' and ships to the patient, but never states subcutaneous vs intramuscular. Dose is given as a volume only (10 ml per week) with no concentration, so the mg content is unknown. Marked '~ starting dose'.
Read from https://remimeds.com/services/nad-plus/ on September 2026.
Price disclosure score: 100 of 100
This scores what Remi Meds publishes about its price, and nothing else. It is not a rating of the product, the clinic, the prescriber or the value — this site has read a price page, not used a product. Across all 106 sellers in the index the scores run from 6 to 100, with a median of 72. Remi Meds sits 5 of 106.
| What is scored | What Remi Meds publishes | Points |
|---|---|---|
| An exact figure | The headline figure is an exact charge for a defined purchase, not a floor and not a first-period rate. | 30of 30 |
| A stated cadence | The seller states the interval it bills on, so a reader knows when the next charge lands. | 20of 20 |
| Visible on the page | Every headline figure (2 figures) is printed where a reader can see it. | 20of 20 |
| A stated route | The seller states how the product is administered, in its own sentence. | 15of 15 |
| A stated dose | Every one of this seller's 2 figures states the dose it buys. | 15of 15 |
| Price disclosure score | This scores what the seller publishes about its price — not the product, the clinic, the prescriber or the value. | 100of 100 |
What Remi Meds does not publish
Each of these is a count over what was actually read, not an impression. 2 figures were read from this seller, and every sentence below is measured against that number.
- None of the 2 figures read from this seller is a standing rate charged by the calendar month.
Figures visible to a reader on the seller’s page
2 of 2
Figures stating a dose
2 of 2
Figures that resolve to a usable price
2 of 2
Source: Counted over the 2 figures read from Remi Meds’s own pages, September 2026. Each track is that figure count.
Where Remi Meds sits
63 other sellers in this index also state a Oral and SubQ route. Ranked with them on price disclosure, Remi Meds is 5 of 64. That is a statement about how completely each one publishes a price, and about nothing else — the figures behind those rows are different kinds of number and several of them state no dose, so they are not a like-for- like price comparison and this site does not present them as one.
Boards Remi Meds appears on
The reading record
This site has read Remi Meds once, in September 2026. A movement can only be shown between two readings taken here, so there is nothing to show yet — and a single reading is a fact about this site's record, never a statement that the seller held its price.
Figures are read from Remi Meds’s own public pages and recorded with the date. What counts as a price, and why a “from” figure is recorded as a floor rather than a rate, is set out on the editorial policy page. Prices in this category move quietly, so the figure above is what the page said on September 2026 and not a promise about today.